{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:37:18Z","timestamp":1777570638238,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1124\/jpet.106.118067","type":"journal-article","created":{"date-parts":[[2007,1,26]],"date-time":"2007-01-26T02:08:59Z","timestamp":1169777339000},"page":"334-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in Rats"],"prefix":"10.1016","volume":"321","author":[{"given":"Gianluigi","family":"Tanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron L.","family":"Ebbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A.","family":"Kopajtic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettye L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy H.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.118067_bib1","doi-asserted-by":"crossref","unstructured":"Berlanga ML, Olsen CM, Chen V, Ikegami A, Herring BE, Duvauchelle CL, and Alcantara AA (2003) Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120: 1149\u20131156.","DOI":"10.1016\/S0306-4522(03)00378-6"},{"key":"10.1124\/jpet.106.118067_bib2","doi-asserted-by":"crossref","unstructured":"Buckley NJ, Bonner TI, Buckley CM, and Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35: 469\u2013476.","DOI":"10.1016\/S0026-895X(25)11261-3"},{"key":"10.1124\/jpet.106.118067_bib3","doi-asserted-by":"crossref","unstructured":"Bymaster FP, Heath I, Hendrix JC, and Shannon HE (1993) Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 267: 16\u201324.","DOI":"10.1016\/S0022-3565(25)39340-7"},{"key":"10.1124\/jpet.106.118067_bib4","doi-asserted-by":"crossref","unstructured":"Carlton PL (1961) Augmentation of the behavioral effects of amphetamine by scopolamine. Psychopharmacologia 2: 377\u2013380.","DOI":"10.1007\/BF00404125"},{"key":"10.1124\/jpet.106.118067_bib5","doi-asserted-by":"crossref","unstructured":"Cheng Y-C and Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099\u20133108.","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"10.1124\/jpet.106.118067_bib6","doi-asserted-by":"crossref","unstructured":"Dar DE, Thiruvazhi M, Abraham P, Kitayama S, Kopajtic TA, Gamliel A, Slusher BS, Carroll FI, and Uhl GR (2005) Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitor. Eur J Med Chem 40: 1013\u20131021.","DOI":"10.1016\/j.ejmech.2005.04.016"},{"key":"10.1124\/jpet.106.118067_bib7","doi-asserted-by":"crossref","unstructured":"De Klippel N, Sarre S, Ebinger G, and Michotte Y (1993) Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Res 630: 57\u201364.","DOI":"10.1016\/0006-8993(93)90642-Z"},{"key":"10.1124\/jpet.106.118067_bib8","doi-asserted-by":"crossref","unstructured":"Doods HN, Mathy MJ, Davidesko D, van Charldorp KJ, de Jonge A, and van Zwieten PA (1987) Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther 242: 257\u2013262.","DOI":"10.1016\/S0022-3565(25)39062-2"},{"key":"10.1124\/jpet.106.118067_bib9","doi-asserted-by":"crossref","unstructured":"Eltze M, Gonne S, Riedel R, Schlotke B, Schudt C, and Simon WA (1985) Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug. Eur J Pharmacol 112: 211\u2013224.","DOI":"10.1016\/0014-2999(85)90498-4"},{"key":"10.1124\/jpet.106.118067_bib10","doi-asserted-by":"crossref","unstructured":"Fink-Jensen A, Fedorova I, Wortwein G, Woldbye DP, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, et al. (2003) Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 74: 91\u201396.","DOI":"10.1002\/jnr.10728"},{"key":"10.1124\/jpet.106.118067_bib11","doi-asserted-by":"crossref","unstructured":"Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, and Tonegawa S (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA 98: 15312\u201315317.","DOI":"10.1073\/pnas.261583798"},{"key":"10.1124\/jpet.106.118067_bib12","doi-asserted-by":"crossref","unstructured":"Gessa GL, Muntoni F, Collu M, Vargiu L, and Mereu G (1985) Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348: 201\u2013203.","DOI":"10.1016\/0006-8993(85)90381-6"},{"key":"10.1124\/jpet.106.118067_bib13","doi-asserted-by":"crossref","unstructured":"Gronier B, Perry KW, and Rasmussen K (2000) Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacology (Berl) 147: 347\u2013355.","DOI":"10.1007\/s002130050002"},{"key":"10.1124\/jpet.106.118067_bib14","doi-asserted-by":"crossref","unstructured":"Ichikawa J, Chung YC, Li Z, Dai J, and Meltzer HY (2002) Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 958: 176\u2013184.","DOI":"10.1016\/S0006-8993(02)03692-2"},{"key":"10.1124\/jpet.106.118067_bib15","doi-asserted-by":"crossref","unstructured":"Ikemoto S (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, d-amphetamine, dopamine and D1\/D2 agonists. Neuroscience 113: 939\u2013955.","DOI":"10.1016\/S0306-4522(02)00247-6"},{"key":"10.1124\/jpet.106.118067_bib16","doi-asserted-by":"crossref","unstructured":"Kalivas PW, Duffy P, DuMars LA, and Skinner C (1988) Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245: 485\u2013492.","DOI":"10.1016\/S0022-3565(25)22646-5"},{"key":"10.1124\/jpet.106.118067_bib17","doi-asserted-by":"crossref","unstructured":"Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, and Newman AH (2001) Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogues alone and in combination with cocaine in rodents. Psychopharmacology 154: 362\u2013374.","DOI":"10.1007\/s002130000667"},{"key":"10.1124\/jpet.106.118067_bib18","doi-asserted-by":"crossref","unstructured":"Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3\u03b1-diphenylmethoxytropane analogues: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288: 302\u2013315.","DOI":"10.1016\/S0022-3565(24)37956-X"},{"key":"10.1124\/jpet.106.118067_bib19","doi-asserted-by":"crossref","unstructured":"Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309: 650\u2013660.","DOI":"10.1124\/jpet.103.060525"},{"key":"10.1124\/jpet.106.118067_bib20","doi-asserted-by":"crossref","unstructured":"Kuczenski R, Segal DS, and Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11: 2703\u20132712.","DOI":"10.1523\/JNEUROSCI.11-09-02703.1991"},{"key":"10.1124\/jpet.106.118067_bib21","doi-asserted-by":"crossref","unstructured":"Li SM, Newman AH, and Katz JL (2005) Place conditioning and locomotor effects of N-substituted, 4\u2032,4\u2033-difluorobenztropine analogs in rats. J Pharmacol Exp Ther 313: 1223\u20131230.","DOI":"10.1124\/jpet.105.084541"},{"key":"10.1124\/jpet.106.118067_bib22","doi-asserted-by":"crossref","unstructured":"Mark GP, Hajnal A, Kinney AE, and Keys AS (1999) Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berl) 143: 47\u201353.","DOI":"10.1007\/s002130050918"},{"key":"10.1124\/jpet.106.118067_bib23","doi-asserted-by":"crossref","unstructured":"Mac\u00eado DS, Sousa FC, Vasconcelos SM, Lima VT, and Viana GS (2001) Different times of withdrawal from cocaine administration cause changes in muscarinic and dopaminergic receptors in rat premotor cortex. Neurosci Lett 312: 129\u2013132.","DOI":"10.1016\/S0304-3940(01)02222-4"},{"key":"10.1124\/jpet.106.118067_bib24","doi-asserted-by":"crossref","unstructured":"Mereu G, Yoon KW, Boi V, Gessa GL, Naes L, and Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141: 395\u2013399.","DOI":"10.1016\/0014-2999(87)90556-5"},{"key":"10.1124\/jpet.106.118067_bib25","doi-asserted-by":"crossref","unstructured":"Newman AH, Allen AC, Izenwasser S, and Katz JL (1994) Novel 3\u03b1- (diphenylmethoxy)-tropane analogues: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 37: 2258\u20132261.","DOI":"10.1021\/jm00041a002"},{"key":"10.1124\/jpet.106.118067_bib26","doi-asserted-by":"crossref","unstructured":"Newman AH and Kulkarni S (2002) Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic\u2013A focus on analogues of benztropine and rimcazole. Med Res Rev 22: 429\u2013464.","DOI":"10.1002\/med.10014"},{"key":"10.1124\/jpet.106.118067_bib27","unstructured":"Paxinos G and Watson C (1987) The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, Australia."},{"key":"10.1124\/jpet.106.118067_bib28","doi-asserted-by":"crossref","unstructured":"Rahman S and McBride WJ (2002) Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area. J Neurochem 80: 646\u2013654.","DOI":"10.1046\/j.0022-3042.2001.00739.x"},{"key":"10.1124\/jpet.106.118067_bib29","doi-asserted-by":"crossref","unstructured":"Scheckel CL and Boff E (1964) Behavioral effects of interacting imipramine and other drugs with D-amphetamine, cocaine, and tetrabenazine. Psychopharmacologia 13: 198\u2013208.","DOI":"10.1007\/BF00413242"},{"key":"10.1124\/jpet.106.118067_bib30","doi-asserted-by":"crossref","unstructured":"Shimosato K, Nagao N, Watanabe S, and Kitayama S (2003) Suppressive effects of trihexyphenidyl on methamphetamine-induced dopamine release as measured by in vivo microdialysis. Synapse 49: 47\u201354.","DOI":"10.1002\/syn.10191"},{"key":"10.1124\/jpet.106.118067_bib31","doi-asserted-by":"crossref","unstructured":"Shimosato K, Watanabe S, and Kitayama S (2001) Differential effects of trihexyphenidyl on place preference conditioning and locomotor stimulant activity of cocaine and methamphetamine. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 364: 74\u201380.","DOI":"10.1007\/s002100100433"},{"key":"10.1124\/jpet.106.118067_bib32","doi-asserted-by":"crossref","unstructured":"Smith JE, Co C, Yin X, Sizemore GM, Liguori A, Johnson WE 3rd, and Martin TJ (2004a) Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 27: 841\u2013850.","DOI":"10.1016\/j.neubiorev.2003.11.002"},{"key":"10.1124\/jpet.106.118067_bib33","doi-asserted-by":"crossref","unstructured":"Smith JE, Vaughn TC, and Co C (2004b) Acetylcholine turnover rates in rat brain regions during cocaine self-administration. J Neurochem 88: 502\u2013512.","DOI":"10.1046\/j.1471-4159.2003.02222.x"},{"key":"10.1124\/jpet.106.118067_bib34","doi-asserted-by":"crossref","unstructured":"Sziraki I, Sershen H, Benuck M, Hashim A, and Lajtha A (1998) Receptor systems participating in nicotine-specific effects. Neurochem Int 33: 445\u2013457.","DOI":"10.1016\/S0197-0186(98)00049-7"},{"key":"10.1124\/jpet.106.118067_bib35","doi-asserted-by":"crossref","unstructured":"Tanda G, Pontieri FE, Frau R, and Di Chiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9: 2077\u20132085.","DOI":"10.1111\/j.1460-9568.1997.tb01375.x"},{"key":"10.1124\/jpet.106.118067_bib36","doi-asserted-by":"crossref","unstructured":"Tanda G, Ebbs A, Newman AH, and Katz JL (2005) Effects of 4\u2032-chloro-3\u03b1- (diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther 313: 613\u2013620.","DOI":"10.1124\/jpet.104.080465"},{"key":"10.1124\/jpet.106.118067_bib37","doi-asserted-by":"crossref","unstructured":"Wilson MC and Schuster CR (1973) Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1: 643\u2013649.","DOI":"10.1016\/0091-3057(73)90027-0"},{"key":"10.1124\/jpet.106.118067_bib38","doi-asserted-by":"crossref","unstructured":"Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, and Katz JL (2000) 3\u2032- and 4\u2032-chloro-substituted analogues of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology 147: 426\u2013435.","DOI":"10.1007\/s002130050012"},{"key":"10.1124\/jpet.106.118067_bib39","doi-asserted-by":"crossref","unstructured":"Xu M, Mizobe F, Yamamoto T, and Kato T (1989) Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res 495: 232\u2013242.","DOI":"10.1016\/0006-8993(89)90217-5"},{"key":"10.1124\/jpet.106.118067_bib40","doi-asserted-by":"crossref","unstructured":"Zahm DS (1999) Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann NY Acad Sci 877: 113\u2013128.","DOI":"10.1111\/j.1749-6632.1999.tb09264.x"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524337954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524337954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.118067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:13:44Z","timestamp":1740003224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524337954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0022356524337954"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.118067","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Muscarinic M1 Receptor Blockade on Cocaine-Induced Elevations of Brain Dopamine Levels and Locomotor Behavior in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.118067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}